Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. There pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response
Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. There pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response
Recent Articles
- LB Pharmaceuticals' Initial Public Offering Sets New Benchmark
- SPX FLOW Expands Brisbane Facility for Enhanced Capabilities
- LB Pharmaceuticals Sets Price for Initial Public Offering
- Fosun International's Journey: Recognized for ESG Excellence and Innovation
- Honoring Charlie Kirk: A Message of Compassion and Hope
- Fosun International Shines in 2025 Admired Companies List
- Unveiling the GFX ETERNA 55: A Game Changer in 8K Filmmaking
- Wesbanco Reveals Details of Its New Preferred Stock Offering
- Labs Investor Group Readies Two Major Funds for Impact
- Sunset World Group Celebrates Independence with Festivities
- Wheaton Precious Metals Backs Carcetti Capital’s Hemlo Mine Deal
- Transforming Executive Risk Coverage with Innovative Solutions
- Carcetti Capital's Strategic Acquisition to Propel Growth
- Transformations of $1000 Investment in Amazon Over a Decade
- Barrick Mining Corporation Completes Major Hemlo Gold Sale
- Investors Rally Behind Lantheus Holdings Amid Lawsuit News
- PayPal's Strategic Investment in Kite Boosts Digital Commerce Potential
- Britannica Takes Legal Action Against Perplexity for Infringement
- Silvercorp's 2025 Sustainability Report Showcases Progress
- Barrick Mining's Strategic Sale of Hemlo Gold Mine Explained
- AuguStar Life Insurance Completes Cash Tender Offer Process
- Investment Growth: Transforming $1000 Into Over $8000 With EQIX
- SK hynix Launches Game-Changing Mobile NAND Solution ZUFS 4.1
- The Incredible Growth of Manhattan Associates Over Two Decades
- High Point University Unveils State-of-the-Art Dental School
- London's Emergence as a Leading Tech Hub in North America
- Empowering Communities to Combat Child Trafficking Together
- Opendoor Welcomes Kaz Nejatian as New CEO and Innovator
- CAPREIT Achieves Major Milestone with International Plaza Sale
- Transforming $100 Into Over $1000: Veeva Systems Success
- Unlocking Flight with the MAVERICK: A Revolutionary Running Shoe
- Teamsters Local 332 Demand Better Conditions at Rally
- Transforming Steel Production: Metal Logic's Clean Solution
- Q2 Metals Updates Exploration Insights on Cisco Lithium Target
- Understanding MercadoLibre's Impressive Growth Over Five Years
- Public Sentiment Declines for Trump amid Economic Concerns
- Tronox Holdings Faces Class Action: What Investors Should Know
- Dive into the Thrills of Kansas City's Haunted Attractions
- Partnership Boosts Corner Exit's Growth in Motorsports Community
- Investors Take Action: Unicoin's Class Action Investigation Overview
- Investigation of Disney's Privacy Practices for Children
- Uncovering the Financial Growth of CommVault Systems Stock
- Empowering Voices: The Call to Protect Our Children
- Exploring Devon Energy's Impressive Growth Over 5 Years
- Opendoor's Fresh Leadership Boosts Stock Potential and Insights
- Zenvia's Q2 2025 Performance Highlights and Future Outlook
- Reflecting on the Legacy and Impact of Charlie Kirk
- Zenvia's Transformative Journey: Recent Q2 2025 Highlights
- Metalsource Mining Welcomes New Leadership with Timothy Ko
- Celebrate National Quesadilla Day with V&V Supremo's Recipes